Cardiorenal protection in experimental hypertension with renal failure: comparison between vasopeptidase inhibition and angiotensin receptor blockade.

MLA

Halleck, Fabian, et al. “Cardiorenal Protection in Experimental Hypertension with Renal Failure: Comparison between Vasopeptidase Inhibition and Angiotensin Receptor Blockade.” Clinical & Experimental Hypertension, vol. 37, no. 1, Feb. 2015, pp. 26–32. EBSCOhost, https://doi.org/10.3109/10641963.2014.897718.

APA

Halleck, F., Schröder, K., Holleck-Weithmann, S., Kossmehl, P., Kreutz, R., & Rothermund, L. (2015). Cardiorenal protection in experimental hypertension with renal failure: comparison between vasopeptidase inhibition and angiotensin receptor blockade. Clinical & Experimental Hypertension, 37(1), 26–32. https://doi.org/10.3109/10641963.2014.897718

Chicago

Halleck, Fabian, Katharina Schröder, Sven Holleck-Weithmann, Peter Kossmehl, Reinhold Kreutz, and Lars Rothermund. 2015. “Cardiorenal Protection in Experimental Hypertension with Renal Failure: Comparison between Vasopeptidase Inhibition and Angiotensin Receptor Blockade.” Clinical & Experimental Hypertension 37 (1): 26–32. doi:10.3109/10641963.2014.897718.